300970 華綠生物
按盤價 
21.740 -0.790 (-3.506%)
21.740 -0.790 (-3.506%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.822 | 7.048 | -3.130 | 1.985 | 5.325 |
| 總資產報酬率 ROA (%) | 1.820 | 4.619 | -2.150 | 1.481 | 4.058 |
| 投入資產回報率 ROIC (%) | 2.026 | 5.157 | -2.410 | 1.644 | 4.412 | 邊際利潤分析 |
| 銷售毛利率 (%) | 15.440 | 16.099 | 5.959 | 13.522 | 16.320 |
| 營業利潤率 (%) | 8.015 | 9.588 | -4.271 | 2.727 | 10.767 |
| 息稅前利潤/營業總收入 (%) | 7.525 | 9.897 | -3.521 | 2.661 | 9.376 |
| 淨利潤/營業總收入 (%) | 8.042 | 9.231 | -4.304 | 2.647 | 10.333 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 103.755 | 93.843 | 91.021 | 140.938 | 85.129 |
| 價值變動淨收益/利潤總額(%) | 0.447 | 0.000 | -0.196 | 1.390 | 5.254 |
| 營業外收支淨額/利潤總額(%) | 0.255 | -3.818 | 0.434 | -3.021 | -1.175 | 償債能力分析 |
| 流動比率 (X) | 4.209 | 3.404 | 2.606 | 2.686 | 3.837 |
| 速動比率 (X) | 2.993 | 2.486 | 1.725 | 1.881 | 2.987 |
| 資產負債率 (%) | 35.438 | 32.293 | 34.098 | 26.005 | 23.118 |
| 帶息債務/全部投入資本 (%) | 11.717 | 13.719 | 15.003 | 10.088 | 13.940 |
| 股東權益/帶息債務 (%) | 595.295 | 538.882 | 482.281 | 814.013 | 599.162 |
| 股東權益/負債合計 (%) | 177.151 | 205.281 | 189.795 | 280.865 | 329.901 |
| 利息保障倍數 (X) | -14.744 | 14.938 | -4.577 | 193.875 | -7.407 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 3.686 | 4.256 | 6.171 | 5.628 | 11.833 |
| 存貨周轉天數 (天) | 72.556 | 69.926 | 71.264 | 72.141 | 75.843 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 20/08/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
